111 related articles for article (PubMed ID: 31892568)
1. The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness.
Hirabayashi S; Hayashi M; Nakayama G; Mii S; Hattori N; Tanabe H; Kanda M; Tanaka C; Kobayashi D; Yamada S; Koike M; Fujiwara M; Takahashi M; Kodera Y
Anticancer Res; 2020 Jan; 40(1):201-211. PubMed ID: 31892568
[TBL] [Abstract][Full Text] [Related]
2. Effect of sidedness on survival among patients with early-stage colon cancer: a SEER-based propensity score matching analysis.
Huang ZS; Wu JW; Li Y; Lin YH; Li XY
World J Surg Oncol; 2021 Apr; 19(1):127. PubMed ID: 33874958
[TBL] [Abstract][Full Text] [Related]
3. Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology).
Kim SR; Song N; Yothers G; Gavin PG; Allegra CJ; Paik S; Pogue-Geile KL
Br J Cancer; 2018 Mar; 118(5):629-633. PubMed ID: 29241223
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of hMLH1 and p53 immunohistochemical status in right-sided colon cancer.
Smyth EF; Sharma A; Sivarajasingham N; Hartley J; Monson JR; Cawkwell L
Dis Colon Rectum; 2004 Dec; 47(12):2086-91; discussion 2091-2. PubMed ID: 15657659
[TBL] [Abstract][Full Text] [Related]
5. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
[TBL] [Abstract][Full Text] [Related]
6. Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
Shen H; Yang J; Huang Q; Jiang MJ; Tan YN; Fu JF; Zhu LZ; Fang XF; Yuan Y
World J Gastroenterol; 2015 Jun; 21(21):6470-8. PubMed ID: 26074686
[TBL] [Abstract][Full Text] [Related]
7. Prognostic effect of sidedness in early stage versus advanced colon cancer.
Kennecke HF; Yin Y; Davies JM; Speers CH; Cheung WY; Lee-Ying R
Health Sci Rep; 2018 Aug; 1(8):e54. PubMed ID: 30623090
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of oncogenesis in colon versus rectal cancer.
Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.
Yu J; Ma X; Cheung KF; Li X; Tian L; Wang S; Wu CW; Wu WK; He M; Wang M; Ng SS; Sung JJ
Oncogene; 2010 Dec; 29(49):6464-74. PubMed ID: 20802524
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer.
Yang L; Xiong Z; Xie Q; He W; Liu S; Kong P; Jiang C; Guo G; Xia L
BMC Cancer; 2018 May; 18(1):558. PubMed ID: 29751794
[TBL] [Abstract][Full Text] [Related]
11. The impact of tumor location on the biological and oncological differences of colon cancer: Multi-institutional propensity score-matched study.
Kishiki T; Kuchta K; Matsuoka H; Kojima K; Asou N; Beniya A; Yamauchi S; Sugihara K; Masaki T
Am J Surg; 2019 Jan; 217(1):46-52. PubMed ID: 30384969
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
[TBL] [Abstract][Full Text] [Related]
13. SPARCL1 exhibits different expressions in left- and right-sided colon cancer and is downregulated via DNA methylation.
Hu H; Wu D; Liu X; Yu H; Xu J; Cai W; Huang Y; Bai R; Zhang J; Gu Y; Zheng S; Ge W
Epigenomics; 2021 Aug; 13(16):1269-1282. PubMed ID: 34435512
[TBL] [Abstract][Full Text] [Related]
14. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
[TBL] [Abstract][Full Text] [Related]
15. Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer.
Huang CW; Tsai HL; Huang MY; Huang CM; Yeh YS; Ma CJ; Wang JY
World J Surg Oncol; 2015 Aug; 13():257. PubMed ID: 26311139
[TBL] [Abstract][Full Text] [Related]
16. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles.
Minoo P; Zlobec I; Peterson M; Terracciano L; Lugli A
Int J Oncol; 2010 Sep; 37(3):707-18. PubMed ID: 20664940
[TBL] [Abstract][Full Text] [Related]
17. Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.
Tanaka M; Chang P; Li Y; Li D; Overman M; Maru DM; Sethi S; Phillips J; Bland GL; Abbruzzese JL; Eng C
Clin Cancer Res; 2011 Jul; 17(13):4531-40. PubMed ID: 21551253
[TBL] [Abstract][Full Text] [Related]
18. Appraisal of Prognostic Interaction between Sidedness and Mucinous Histology in Colon Cancer: A Population-Based Study Using Inverse Probability Propensity Score Weighting.
Wang ZX; Yang LP; Wu HX; Yang DD; Ding PR; Xie D; Chen G; Li YH; Wang F; Xu RH
J Cancer; 2019; 10(2):388-396. PubMed ID: 30719132
[No Abstract] [Full Text] [Related]
19. The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.
Demurtas L; Puzzoni M; Giampieri R; Ziranu P; Pusceddu V; Mandolesi A; Cremolini C; Masi G; Gelsomino F; Antoniotti C; Loretelli C; Meriggi F; Zaniboni A; Falcone A; Cascinu S; Scartozzi M
Br J Cancer; 2017 Jul; 117(3):315-321. PubMed ID: 28632725
[TBL] [Abstract][Full Text] [Related]
20. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site.
Lenz HJ; Danenberg KD; Leichman CG; Florentine B; Johnston PG; Groshen S; Zhou L; Xiong YP; Danenberg PV; Leichman LP
Clin Cancer Res; 1998 May; 4(5):1227-34. PubMed ID: 9607581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
